HEADER PROTEIN BINDING/PEPTIDE 27-MAY-10 3N7Y TITLE CRYSTAL STRUCTURE OF THE GRB2 SH2 DOMAIN IN COMPLEX WITH A 20-MEMBERED TITLE 2 MACROCYCLIC LIGAND HAVING THE SEQUENCE PYVNV COMPND MOL_ID: 1; COMPND 2 MOLECULE: GROWTH FACTOR RECEPTOR-BOUND PROTEIN 2; COMPND 3 CHAIN: A, B, C; COMPND 4 FRAGMENT: SH2 DOMAIN; COMPND 5 SYNONYM: ADAPTER PROTEIN GRB2, SH2/SH3 ADAPTER GRB2, PROTEIN ASH; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: 20-MEMBERED PEPTIDE-LIKE MACROCYCLIC LIGAND; COMPND 9 CHAIN: D, E, F; COMPND 10 ENGINEERED: YES; COMPND 11 OTHER_DETAILS: PYVNV-CONTAINING SEQUENCE SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: GRB2, ASH; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: SG13009; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PQE-60; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES KEYWDS LIGAND PREORGANIZATION, MACROCYCLES, MACROCYCLIC LIGANDS, GOLGI KEYWDS 2 APPARATUS, HOST-VIRUS INTERACTION, PHOSPHOPROTEIN, PROTEIN BINDING- KEYWDS 3 PEPTIDE COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR B.B.WHIDDON,J.H.CLEMENTS,S.F.MARTIN REVDAT 4 16-OCT-24 3N7Y 1 REMARK REVDAT 3 15-NOV-23 3N7Y 1 LINK ATOM REVDAT 2 06-SEP-23 3N7Y 1 LINK REVDAT 1 12-JAN-11 3N7Y 0 JRNL AUTH J.E.DELORBE,J.H.CLEMENTS,B.B.WHIDDON,S.F.MARTIN JRNL TITL THERMODYNAMIC AND STRUCTURAL EFFECTS OF MACROCYCLIZATION AS JRNL TITL 2 A CONSTRAINING METHOD IN PROTEIN-LIGAND INTERACTIONS. JRNL REF ACS MED.CHEM.LETT. V. 1 448 2010 JRNL REFN ISSN 1948-5875 JRNL PMID 21116482 JRNL DOI 10.1021/ML100142Y REMARK 2 REMARK 2 RESOLUTION. 2.02 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.02 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 25587 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.180 REMARK 3 FREE R VALUE : 0.222 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 2529 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2571 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 371 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.52900 REMARK 3 B22 (A**2) : -0.52900 REMARK 3 B33 (A**2) : 1.05700 REMARK 3 B12 (A**2) : -0.07100 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.335 ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.097 ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3N7Y COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-NOV-10. REMARK 100 THE DEPOSITION ID IS D_1000059493. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-FEB-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : BLUE MAX-FLUX CONFOCAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25618 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.020 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 5.700 REMARK 200 R MERGE (I) : 0.09800 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.02 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.09 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 5.40 REMARK 200 R MERGE FOR SHELL (I) : 0.35500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 1JYR REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.23 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.63 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: LIGAND IN LYOHPILIZED POWER FORM WAS REMARK 280 DISSOLVED IN A 10.0 MG/ML SOLUTION OF GRB2 SH2 IN WATER SUCH TO REMARK 280 GIVE A PROTEIN/LIGAND MOLAR RATIO OF 1:2. 3.5 UL OF THIS REMARK 280 SOLUTION WAS MIXED WITH 3.5 UL OF 20% V/V ISOPROPANOL, 20% W/V REMARK 280 POLYETHYLENE GLYCOL MW 4,000, 0.1 M SODIUM CITRATE DIHYDRATE, PH REMARK 280 5.6 TO CREATE THE HANGING DROP, WHICH YIELDED CRYSTALS OF THE REMARK 280 PROTEIN-LIGAND COMPLEX AFTER TWO WEEKS, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 298KK REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 64.00600 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 32.00300 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 32.00300 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 64.00600 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4, 5 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THERE ARE THREE BIOLOGICAL UNITS IN THE ASYMMETRIC UNIT REMARK 300 (CHAINS A, B, AND C) EACH PRESENT AS A COMPLEX WITH THE MACROCYCLIC REMARK 300 LIGAND (CHAINS D, E, AND F) REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3670 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9950 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -28.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 -0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 64.00600 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 760 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 6060 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3550 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10350 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -27.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, F REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 -0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 64.00600 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 770 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 6130 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 5 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 720 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 6290 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH C 369 LIES ON A SPECIAL POSITION. REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 MET A 55 CB CG CE REMARK 480 LYS A 76 CE NZ REMARK 480 ARG A 78 CG CD NE CZ NH1 NH2 REMARK 480 MET B 55 CE REMARK 480 LYS B 56 CG CD CE NZ REMARK 480 LYS B 76 NZ REMARK 480 ARG B 78 CG CD NE CZ NH1 NH2 REMARK 480 MET C 55 N CA REMARK 480 LYS C 56 CD CE NZ REMARK 480 LYS C 76 CE NZ REMARK 480 ARG C 78 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TRP A 121 -84.42 -123.69 REMARK 500 TRP B 121 -93.73 -128.36 REMARK 500 LYS C 64 45.20 -86.38 REMARK 500 TRP C 121 -90.75 -123.43 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN D OF 20-MEMBERED PEPTIDE REMARK 800 -LIKE MACROCYCLIC LIGAND REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN E OF 20-MEMBERED PEPTIDE REMARK 800 -LIKE MACROCYCLIC LIGAND REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN F OF 20-MEMBERED PEPTIDE REMARK 800 -LIKE MACROCYCLIC LIGAND REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1BM2 RELATED DB: PDB REMARK 900 RELATED ID: 3N84 RELATED DB: PDB DBREF 3N7Y A 55 152 UNP P62993 GRB2_HUMAN 55 152 DBREF 3N7Y B 55 152 UNP P62993 GRB2_HUMAN 55 152 DBREF 3N7Y C 55 152 UNP P62993 GRB2_HUMAN 55 152 DBREF 3N7Y D 1 5 PDB 3N7Y 3N7Y 1 5 DBREF 3N7Y E 1 5 PDB 3N7Y 3N7Y 1 5 DBREF 3N7Y F 1 5 PDB 3N7Y 3N7Y 1 5 SEQRES 1 A 98 MET LYS PRO HIS PRO TRP PHE PHE GLY LYS ILE PRO ARG SEQRES 2 A 98 ALA LYS ALA GLU GLU MET LEU SER LYS GLN ARG HIS ASP SEQRES 3 A 98 GLY ALA PHE LEU ILE ARG GLU SER GLU SER ALA PRO GLY SEQRES 4 A 98 ASP PHE SER LEU SER VAL LYS PHE GLY ASN ASP VAL GLN SEQRES 5 A 98 HIS PHE LYS VAL LEU ARG ASP GLY ALA GLY LYS TYR PHE SEQRES 6 A 98 LEU TRP VAL VAL LYS PHE ASN SER LEU ASN GLU LEU VAL SEQRES 7 A 98 ASP TYR HIS ARG SER THR SER VAL SER ARG ASN GLN GLN SEQRES 8 A 98 ILE PHE LEU ARG ASP ILE GLU SEQRES 1 B 98 MET LYS PRO HIS PRO TRP PHE PHE GLY LYS ILE PRO ARG SEQRES 2 B 98 ALA LYS ALA GLU GLU MET LEU SER LYS GLN ARG HIS ASP SEQRES 3 B 98 GLY ALA PHE LEU ILE ARG GLU SER GLU SER ALA PRO GLY SEQRES 4 B 98 ASP PHE SER LEU SER VAL LYS PHE GLY ASN ASP VAL GLN SEQRES 5 B 98 HIS PHE LYS VAL LEU ARG ASP GLY ALA GLY LYS TYR PHE SEQRES 6 B 98 LEU TRP VAL VAL LYS PHE ASN SER LEU ASN GLU LEU VAL SEQRES 7 B 98 ASP TYR HIS ARG SER THR SER VAL SER ARG ASN GLN GLN SEQRES 8 B 98 ILE PHE LEU ARG ASP ILE GLU SEQRES 1 C 98 MET LYS PRO HIS PRO TRP PHE PHE GLY LYS ILE PRO ARG SEQRES 2 C 98 ALA LYS ALA GLU GLU MET LEU SER LYS GLN ARG HIS ASP SEQRES 3 C 98 GLY ALA PHE LEU ILE ARG GLU SER GLU SER ALA PRO GLY SEQRES 4 C 98 ASP PHE SER LEU SER VAL LYS PHE GLY ASN ASP VAL GLN SEQRES 5 C 98 HIS PHE LYS VAL LEU ARG ASP GLY ALA GLY LYS TYR PHE SEQRES 6 C 98 LEU TRP VAL VAL LYS PHE ASN SER LEU ASN GLU LEU VAL SEQRES 7 C 98 ASP TYR HIS ARG SER THR SER VAL SER ARG ASN GLN GLN SEQRES 8 C 98 ILE PHE LEU ARG ASP ILE GLU SEQRES 1 D 5 PTR VAL ASN VAL 011 SEQRES 1 E 5 PTR VAL ASN VAL 011 SEQRES 1 F 5 PTR VAL ASN VAL 011 MODRES 3N7Y PTR D 1 TYR O-PHOSPHOTYROSINE MODRES 3N7Y PTR E 1 TYR O-PHOSPHOTYROSINE MODRES 3N7Y PTR F 1 TYR O-PHOSPHOTYROSINE HET PTR D 1 16 HET 011 D 5 9 HET PTR E 1 16 HET 011 E 5 9 HET PTR F 1 16 HET 011 F 5 9 HETNAM PTR O-PHOSPHOTYROSINE HETNAM 011 7-AMINOHEPTANOIC ACID HETSYN PTR PHOSPHONOTYROSINE FORMUL 4 PTR 3(C9 H12 N O6 P) FORMUL 4 011 3(C7 H15 N O2) FORMUL 7 HOH *371(H2 O) HELIX 1 1 PRO A 66 LYS A 76 1 11 HELIX 2 2 SER A 127 HIS A 135 1 9 HELIX 3 3 PRO B 66 LYS B 76 1 11 HELIX 4 4 SER B 127 HIS B 135 1 9 HELIX 5 5 PRO C 66 GLN C 77 1 12 HELIX 6 6 SER C 127 THR C 138 1 12 SHEET 1 A 5 PHE A 83 GLU A 87 0 SHEET 2 A 5 PHE A 95 PHE A 101 -1 O SER A 96 N ARG A 86 SHEET 3 A 5 ASP A 104 ARG A 112 -1 O PHE A 108 N LEU A 97 SHEET 4 A 5 TYR A 118 PHE A 119 -1 O PHE A 119 N LEU A 111 SHEET 5 A 5 LYS A 124 PHE A 125 -1 O PHE A 125 N TYR A 118 SHEET 1 B 6 LYS B 124 PHE B 125 0 SHEET 2 B 6 TYR B 118 PHE B 119 -1 N TYR B 118 O PHE B 125 SHEET 3 B 6 ASP B 104 ARG B 112 -1 N LEU B 111 O PHE B 119 SHEET 4 B 6 PHE B 95 PHE B 101 -1 N LEU B 97 O PHE B 108 SHEET 5 B 6 ALA B 82 GLU B 87 -1 N ARG B 86 O SER B 96 SHEET 6 B 6 ARG B 149 ASP B 150 1 O ARG B 149 N PHE B 83 SHEET 1 C 5 PHE C 83 GLU C 87 0 SHEET 2 C 5 PHE C 95 PHE C 101 -1 O SER C 96 N ARG C 86 SHEET 3 C 5 ASP C 104 ARG C 112 -1 O PHE C 108 N LEU C 97 SHEET 4 C 5 TYR C 118 PHE C 119 -1 O PHE C 119 N LEU C 111 SHEET 5 C 5 LYS C 124 PHE C 125 -1 O PHE C 125 N TYR C 118 LINK C PTR D 1 N VAL D 2 1555 1555 1.33 LINK N PTR D 1 C 011 D 5 1555 1555 1.33 LINK C VAL D 4 N 011 D 5 1555 1555 1.33 LINK C PTR E 1 N VAL E 2 1555 1555 1.33 LINK N PTR E 1 C 011 E 5 1555 1555 1.33 LINK C VAL E 4 N 011 E 5 1555 1555 1.33 LINK C PTR F 1 N VAL F 2 1555 1555 1.33 LINK N PTR F 1 C 011 F 5 1555 1555 1.33 LINK C VAL F 4 N 011 F 5 1555 1555 1.33 SITE 1 AC1 19 ARG A 67 ARG A 86 SER A 88 SER A 90 SITE 2 AC1 19 SER A 96 HIS A 107 PHE A 108 LYS A 109 SITE 3 AC1 19 LEU A 120 TRP A 121 ASN A 143 HOH A 154 SITE 4 AC1 19 HOH A 188 ASN C 143 GLN C 144 HOH C 168 SITE 5 AC1 19 HOH C 170 HOH D 86 HOH D 287 SITE 1 AC2 21 ASN A 143 GLN A 144 HOH B 32 ARG B 67 SITE 2 AC2 21 ARG B 86 SER B 88 SER B 90 SER B 96 SITE 3 AC2 21 GLN B 106 HIS B 107 PHE B 108 LYS B 109 SITE 4 AC2 21 LEU B 120 TRP B 121 HOH B 164 HOH B 296 SITE 5 AC2 21 HOH E 104 HOH E 121 HOH E 202 HOH E 205 SITE 6 AC2 21 HOH E 275 SITE 1 AC3 20 GLN B 106 GLN B 144 HOH B 163 HOH B 198 SITE 2 AC3 20 HOH B 207 ARG C 67 ARG C 86 SER C 88 SITE 3 AC3 20 GLU C 89 SER C 90 SER C 96 HIS C 107 SITE 4 AC3 20 PHE C 108 LYS C 109 LEU C 120 TRP C 121 SITE 5 AC3 20 HOH F 47 HOH F 166 HOH F 170 HOH F 285 CRYST1 83.162 83.162 96.009 90.00 90.00 120.00 P 32 2 1 18 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012025 0.006942 0.000000 0.00000 SCALE2 0.000000 0.013885 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010416 0.00000